Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. The company operates through four segments: BD Medical Essentials, BD Connected Care, BD BioPharma Systems and BD Interventional. BD Medical Essentials segment includes medication delivery solutions and specimen management. BD Connected Care segment includes medication management solutions and advanced patient monitoring. BD Interventional segment includes urology and critical care, peripheral intervention and surgery.
Becton Dickinson and Co 'in P/E oranı 26.2903 'dir
Becton Dickinson and Co 'in CEO'su kimdir?
Mr. Thomas Polen 2014 'den beri şirketle birlikte olan Becton Dickinson and Co 'in Chairman of the Board 'ıdır.
BDX hissesinin fiyat performansı nasıl?
BDX 'in mevcut fiyatı $155.9 'dir, son işlem günde 0.37% tăng lên etti.
Becton Dickinson and Co için ana iş temaları veya sektörler nelerdir?
Becton Dickinson and Co Health Care endüstrisine ait ve sektör Health Care 'dir
Becton Dickinson and Co 'in piyasa değerlemesi nedir?
Becton Dickinson and Co 'in mevcut piyasa değerlemesi $44.3B 'dir
Becton Dickinson and Co al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 15 analist Becton Dickinson and Co için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 4 al, 10 tut, 0 sat ve 4 güçlü sat içermektedir